Disclosed herein are compositions and methods for using human-derived Janthinobacterium lividum. Compositions improve skin health. Methods may include applying human-derived Janthinobacterium lividum over a host or host area, such as skin or mucosa, to minimize the presence of one or more microbes, maximize therapeutic effects, and/or improve health. A method to minimize a pathogenic microbe may include applying to a surface a composition including human-derived Janthinobacterium lividum and an acceptable carrier. Compositions and methods may include a prebiotic to maximize growth and/or metabolites. Compositions and methods may include human-derived Janthinobacterium lividum metabolites, such as violacein, prodigiosin, indole-3-carboxaldehyde, and lantibiotics, and/or other Postbiotics.

The present invention concerns an auxochrome substituent for an oxidative dye coupler. The auxochrome substituent enables ready developer reaction with the coupler to form azomethine and leuco dyes. Manipulation of the auxochrome substituent enables a bathochromic or hypsochromic shift of the light absorbance by the azomethine dye formed with the auxochrome substituted coupler.

Multiple emulsions comprising an internal phase which is an oil continuous nanoemulsion are described. The multiple emulsions are water continuous, stable, provide moisturizing benefits and can comprise a high concentration of water soluble actives.

A composition and method to increase skin thickness. The composition, preferably a topical lotion, may comprise skin thickening agents and a delivery agent, which in combination increases skin thickness, and may help reduce the possibility of injuries related to individuals suffering from thin or thinning skin, such as bruising or skin tears.

The present invention relates to a composition for skin whitening, and more particularly, to a topical preparation, cosmetic or health functional food composition for skin whitening, which includes carvedilol as an active ingredient. The composition of the present invention, which includes carvedilol as an active ingredient, exhibits a whitening effect by suppressing the expression of a melanin synthesis gene by reducing MITF through inhibition of CREB phosphorylation in normal human melanocytes (NHMs), and gradually weakens cell tyrosinase activity over time, lowering the risk of a side effect of pigmentation. Therefore, the composition is expected to be effectively used in development of materials for cosmetics and health functional food and related industries in safe and effective ways.

The present disclosure relates to a composition for preventing, alleviating or treating pruritus and/or atopy using an N-acetylamino acid or an N-acylamino acid having almost no side effects on the human body. Also, the present disclosure relates to a cosmetic composition for moisturizing skin or soothing skin. The composition of the present disclosure may be utilized to ameliorate a problematic skin condition caused by various causes, or to safely and effectively alleviate or treat pruritus and/or atopy without concern about side effects.

The present disclosure relates to compounds that are capable of inhibiting the mitochondrial pyruvate carrier and promoting hair growth. The disclosure further relates to methods of promoting hair growth or treating conditions or disorders affecting hair growth, such as baldness or alopecia.

It is an object of the present disclosure to provide an agent for coloring keratinous material, in particular human hair, comprising (a1) at least one amino-functionalized silicone polymer, and (a2) at least pigment,
the weight ratio of all the pigments (a2) contained in the composition to all the amino-functionalized silicone polymers (a1) contained in the composition, i.e., the weight ratio (a2)/(a1), being not more than 0.95. A second subject matter is a method for dyeing keratin material, wherein the agent is applied to the keratin material.

The present invention relates to a hair cosmetic containing the following components (A) to (E): (A) a compound represented by the following general formula (1) or a salt thereof: ##STR00001## wherein a broken line represents the presence or absence of a π bond; R.sup.1 represents a hydroxy group or an acetoxy group; R.sup.2 represents a hydrogen atom or —COOR (R is a hydrogen atom, a methyl group, or an ethyl group); and R.sup.3 represents a hydrogen atom, an acetyl group, a methyl group, or an ethyl group; (B) an alkaline agent; (C) a buffering agent; (D) an anionic surfactant; and (E) a cationic polymer having a cation charge density of 0.01 meq/g or more and 4.8 meq/g or less, a mass ratio of the component (A) to the component (E) [(A)/(E)] being 0.05 or more and less than 2.

Disclosed herein are compositions and methods for using human-derived Janthinobacterium lividum. Compositions improve skin health. Methods may include applying human-derived Janthinobacterium lividum over a host or host area, such as skin or mucosa, to minimize the presence of one or more microbes, maximize therapeutic effects, and/or improve health. A method to minimize a pathogenic microbe may include applying to a surface a composition including human-derived Janthinobacterium lividum and an acceptable carrier. Compositions and methods may include a prebiotic to maximize growth and/or metabolites. Compositions and methods may include human-derived Janthinobacterium lividum metabolites, such as violacein, prodigiosin, indole-3-carboxaldehyde, and lantibiotics, and/or other Postbiotics.